Headline News about Merck & Co
Smart Money Is Betting Big In MRK Options
March 25, 2024
Via Benzinga
Looking At Merck & Co's Recent Unusual Options Activity
March 20, 2024
Via Benzinga
The Most Important Catalyst For Merck's Stock In 2024 Could Be Sotatercept Launch, Analyst Says
March 27, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Via Benzinga
Exposures
Product Safety
Via Talk Markets
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
March 09, 2024
Via Talk Markets
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|